Sentio Systematic Evaluation

计划入组 100 人 · 首次发布于 2025 年 9 月 8 日

Clinical Study of Sanjin Tablets for the Treatment of Acute Simple Lower Urinary Tract Infection

计划入组 252 人 · 首次发布于 2018 年 9 月 5 日

Lay User Evaluation of the Panbio™ HCV Self-Test

计划入组 1,185 人 · 首次发布于 2024 年 9 月 20 日

MSC2(SanBio)

MSC1(SanBio)

HeartiCellgram-AMI

SanBio, Inc.

United States

SunBio, Inc.

South Korea

SwanBio Therapeutics, Inc.

United States

Stem Cell Therapy Restores Brain Activity in Rats After Stroke, SanBio's SB623 Shows Promise

TBI Therapeutics Advance Through Clinical Trials: SanBio's SB623 Receives Sakigake Designation

Mixed Results for Cancer and Neurological Drugs, Regulatory Scrutiny Intensifies for PBMs